Global pharmaceutical packaging market 2016–2020 — market segmentation by product type, material type & packaging type
Research and Markets has announced the addition of the "Global Pharmaceutical Packaging Market 2016–2020" report to their offering.
The report predicts the global pharmaceutical packaging market to grow at a CAGR of around 6% during the forecast period.
A major trend is the rise in demand for ampules and vials. These containers are popular owing to the high bioavailability and fast action rates of the drug, and the drug is administered in the injectable form. In addition, trends that will keep on pushing the market are integration with protective technologies, popularity of superior plastics as a raw material, and growth in contract manufacturing will further fuel the growth of the market
.According to the report, increased adoption of prefillable syringes is a major driver, which is expected to propel the growth of the market during the forecast period. These syringes are gaining popularity because of the rise in chronic diseases where patients need to self-administer drugs multiple times in a week. This is fueling innovations in syringes such as multi-chambered syringes and technology to minimize leachables and extractables, thus driving the growth of global market.
Further, the report states that one of the key challenges is the fragmentation of the market. Most of the players operating in the market are micro, small, and medium-sized enterprises (MSMEs). The business models of large corporations are different from the business models of these small companies.
Plastic pharmaceutical packaging accounted for a market share of around 61% during 2015. Plastic is the most preferred packaging material as it is available in a variety of grades, has significant barrier properties, is chemically inert, and can be used to create attractive packages with esthetic appeal, which helps in the marketing and promotional activities for the drug. The grades of plastic used for packaging include PE, PP, polyolefin, PET, and PVC.
North America dominated the market during 2015, accounting for a market share of around 35%. The pharmaceutical packaging market in North America is dominated by the US, which is a highly competitive market.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.